Evidence map›Paper›PMID 35497846›Full record

ArticleRSC advances2020

Screening and characterisation of CdTe/CdS quantum dot-binding peptides for material surface functionalisation.

Thanawat Suwatthanarak, Masayoshi Tanaka, Taisuke Minamide, Andrew J Harvie, Abiral Tamang, Kevin Critchley, Stephen D Evans, Mina Okochi

Abstract read
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Thanawat SuwatthanarakDepartment of Chemical Science and Engineering, Tokyo Institute of Technology 2-12-1, O-okayama, Meguro-ku Tokyo 152-8552 Japan okochi.m.aa@m.titech.ac.jp.ORCID https://orcid.org/0000-0003-2326-8176
Masayoshi TanakaDepartment of Chemical Science and Engineering, Tokyo Institute of Technology 2-12-1, O-okayama, Meguro-ku Tokyo 152-8552 Japan okochi.m.aa@m.titech.ac.jp.ORCID https://orcid.org/0000-0002-4701-5352
Taisuke MinamideDepartment of Chemical Science and Engineering, Tokyo Institute of Technology 2-12-1, O-okayama, Meguro-ku Tokyo 152-8552 Japan okochi.m.aa@m.titech.ac.jp.
Andrew J HarvieSchool of Physics and Astronomy, University of Leeds Leeds LS2 9JT UK.ORCID https://orcid.org/0000-0002-7840-6639
Abiral TamangSchool of Physics and Astronomy, University of Leeds Leeds LS2 9JT UK.
Kevin CritchleySchool of Physics and Astronomy, University of Leeds Leeds LS2 9JT UK.
Stephen D EvansSchool of Physics and Astronomy, University of Leeds Leeds LS2 9JT UK.
Mina OkochiDepartment of Chemical Science and Engineering, Tokyo Institute of Technology 2-12-1, O-okayama, Meguro-ku Tokyo 152-8552 Japan okochi.m.aa@m.titech.ac.jp.ORCID https://orcid.org/0000-0002-1727-2948

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quantum dots (QDs) are promising nanomaterials due to their unique photophysical properties. For them to be useful in biological applications, the particle surface generally needs to be conjugated to biological molecules, such as antibodies. In this study, we screened CdTe/CdS QD-binding peptides from a phage display library as linkers for simple and bio-friendly QD modification. Among five QD-binding peptide candidates, a series of truncated peptides designed from two high-affinity peptides were subjected to an array-based binding assay with QDs to assess their functional core sequences and characteristics. Linking these isolated, shortened peptides (PWSLNR and SGVYK) with an antibody-binding peptide (NKFRGKYK) created dual-functional peptides that are capable of QD surface functionalisation by antibodies. Consequently, the dual-functional peptides could mediate anti-CD9 antibody functionalisation onto CdTe/CdS QD surface; CD9 protein imaging of cancer cells was also demonstrated. Our proposed peptides offer an effective vehicle for QD surface functionalisation in biological applications.

Identifiers

PMID35497846
PMCPMC9049935

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.